Log in to save to my catalogue

IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19

IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7ea3562a4c7b4cf2bee002d42f241bc4

IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19

About this item

Full title

IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19

Publisher

England: Springer

Journal title

Molecular Medicine, 2020-10, Vol.26 (1), p.97-97, Article 97

Language

English

Formats

Publication information

Publisher

England: Springer

Subjects

Subjects and topics

More information

Scope and Contents

Contents

COVID-19 is a viral respiratory disease caused by the severe acute respiratory syndrome-Coronavirus type 2 (SARS-CoV-2). Patients with this disease may be more prone to venous or arterial thrombosis because of the activation of many factors involved in it, including inflammation, platelet activation and endothelial dysfunction. Interferon gamma ind...

Alternative Titles

Full title

IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_7ea3562a4c7b4cf2bee002d42f241bc4

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7ea3562a4c7b4cf2bee002d42f241bc4

Other Identifiers

ISSN

1076-1551

E-ISSN

1528-3658

DOI

10.1186/s10020-020-00230-x

How to access this item